Horan Securities, Inc. Novo Nordisk A S Transaction History

Horan Securities, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	SELL	$132.34 - $159.14 $10,057 - $12,094	-76 Reduced 37.44%	127 $20,000
Q3 2022 Oct 12, 2022	BUY	$95.28 - $116.93 $95 - $116	1 Added 0.5%	203 $20,000
Q2 2022 Jul 19, 2022	BUY	$103.24 - $121.81 $103 - $121	1 Added 0.5%	202 $23,000
Q4 2021 Feb 09, 2022	BUY	$95.88 - $117.08 $19,271 - $23,533	201 New	201 $22,000

1,955

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $240B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Horan Securities, Inc., based on Form 13F filings with the SEC.

Stay updated on Horan Securities, Inc. with notifications on news.